Eleuthero (Siberian ginseng) Eleutherococcus senticosus (Rupr. & Maxim.) Maxim.
Also called: Siberian ginseng, eleuthero root, Acanthopanax senticosus (synonym)
Eleuthero is a perennial plant found mainly in northern Asia whose root is used in herbal products. Despite the name Siberian ginseng, it is not a species of ginseng (Panax). In the EU it has a traditional-use monograph for fatigue and weakness.
- Category
- Botanical
- Part used
- Root
- Strongest evidence
- C Limited
- Native range
- Native from the Russian Far East to central China and Japan (POWO: "Russian Far East to C. China and Japan.")
- Reviewed
- 2026-10-29
Class 1 Well studied in people. This entry cites 11 reports of RCTs of eleuthero alone taken by mouth (sources 2-4, 9-16) versus placebo or an active or untreated control. Sources 12 and 13 (same group, design and calcium co-treatment) may describe one trial, so at least 10 distinct RCTs. [2]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CBrain, mood and sleep3 topics
CMuscles and exercise1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Chronic fatigue in adults | C | RCT of 96 adults with fatigue for 6 months or longer: fatigue fell in both groups and differences versus placebo were not significant; overall efficacy was not demonstrated. [2] |
| Stress-related fatigue and reduced working capacity | C | In an RCT of 144 adults, adding 120 mg/day root extract to stress-management training gave, if any, negligible benefit; almost all measures improved over time without group differences. [3] |
| Aerobic exercise performance in trained runners | C | In an 8-week double-blind trial in 20 highly trained distance runners, the extract did not differ from placebo on heart rate, oxygen uptake, time to exhaustion, lactate or perceived exertion. [4] |
| Fatigue and weakness (EU traditional use) | C | The EU monograph accepts use for symptoms of asthenia such as fatigue and weakness exclusively on the basis of long-standing use, not clinical-trial proof of efficacy. [5] |
Main constituents: Eleutherosides (including eleutherosides B and E) and polysaccharides, named as active components [1]; Isofraxidin, named with eleutherosides B and E as an active constituent [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Stated in the EU traditional-use monograph (2014): daily, e.g. 0.5-4 g comminuted root as tea, 0.75-3 g powdered root, or dry aqueous extract 90-180 mg; not to be taken for more than 2 months. [5]
- Studied in a trial: 120 mg/day root extract for 8 weeks. [3]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingSafety during pregnancy and lactation has not been established; in the absence of sufficient data, use is not recommended.
1 statement in the profile.
Details and sources - Interactions with medicines2 listed
Digoxin; CYP2C9 and CYP2E1 substrates
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked. The profile notes other test results.
Details and sources - FDA new dietary ingredient notifications3 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
EU HMPC traditional use (2014), adolescents and adults: daily 0.5-4 g comminuted root as tea; 0.75-3 g powdered root …
Details and sources
- Insomnia, irritability, tachycardia and headaches may occur (frequency not known). [5]
- Use in children under 12 is not recommended; safety in pregnancy and lactation has not been established and use is not recommended. [5]
- Case report: subarachnoid hemorrhage in a woman using a supplement that also contained red clover and dong quai; symptoms resolved after stopping. [1]
Interactions
| With | What happens |
|---|---|
| Digoxin | In a case report, Siberian ginseng was associated with elevated serum digoxin levels; it may also cause falsely elevated digoxin assay results. [1] |
| Drugs metabolized by CYP2C9 or CYP2E1 | In vitro, eleutherosides B and E may inhibit CYP2C9 and CYP2E1; clinical relevance has yet to be determined. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
Regulatory status
- US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for safety and labeling, and an NDI notification is required for certain new dietary ingredients. [7]
- EU: HMPC community herbal monograph (2014) for traditional use in symptoms of asthenia such as fatigue and weakness. [5]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 3 entries naming Eleutherococcus senticosus (earliest NDI 878 submitted 2015-08-04; most recent NDI 1208 submitted 2021-06-01). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. All three name it as one component of a multi-botanical ingredient. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of eleuthero (Eleutherococcus senticosus) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
- NTP technical reports list checked: no report on this plant. [P4]
- The EU monograph states that adequate tests on reproductive toxicity and carcinogenicity have not been performed. [P5]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- Harkey et al. 2001: 25 US ginseng-type products were correctly labeled to genus, but eleutheroside content varied 43-fold (capsules) and 200-fold (liquids) and differed from label claims. [P6]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each component that is a dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under (a)(1)(ii). [P7]
- Eleutheroside marker assay (HPLC or LC-MS/MS) — Eleutheroside content varied up to 200-fold between commercial products and differed from labeled amounts. [P6]
- Compliance with the Ph. Eur. monograph for Eleutherococcus root (1419) — Specified for the herbal substance in the EU HMPC monograph. [P5]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- EU HMPC traditional use (2014), adolescents and adults: daily 0.5-4 g comminuted root as tea; 0.75-3 g powdered root; liquid extract (DER 1:1) 2-3 ml; dry aqueous extract (DER 15-17:1) 90-180 mg; tincture 10-15 ml; not for more than 2 months. [P5]
Pregnancy and breastfeeding
- Safety during pregnancy and lactation has not been established; in the absence of sufficient data, use is not recommended. No fertility data available. [P5]
Sources for this profile
- Memorial Sloan Kettering Cancer Center. About Herbs: Siberian Ginseng (last updated February 15, 2022), 2022-02-15. mskcc.org
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (1,060 agents, Volumes 1-142; checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports series list (607 reports; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- EMA HMPC. Community herbal monograph on Eleutherococcus senticosus (Rupr. et Maxim.) Maxim., radix (EMA/HMPC/680618/2013, final, 25 March 2014), 2014-03-25. ema.europa.eu
- Harkey MR, et al. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001;73(6):1101-6 (PMID 11382666), 2001-06. pubmed.ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources
- Memorial Sloan Kettering Cancer Center. About Herbs: Siberian Ginseng (last updated February 15, 2022), 2022-02-15. mskcc.org
- Hartz AJ, et al. Randomized controlled trial of Siberian ginseng for chronic fatigue. Psychol Med 2004;34(1):51-61 (PMID 14971626), 2004-01. pubmed.ncbi.nlm.nih.gov
- Schaffler K, et al. No benefit adding Eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study. Pharmacopsychiatry 2013;46(5):181-90 (PMID 23740477), 2013-07. pubmed.ncbi.nlm.nih.gov
- Dowling EA, et al. Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance. Med Sci Sports Exerc 1996;28(4):482-9 (PMID 8778554), 1996-04. pubmed.ncbi.nlm.nih.gov
- EMA HMPC. Community herbal monograph on Eleutherococcus senticosus (Rupr. et Maxim.) Maxim., radix (EMA/HMPC/680618/2013, final, 25 March 2014), 2014-03-25. ema.europa.eu
- Harkey MR, et al. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001;73(6):1101-6 (PMID 11382666), 2001-06. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim.: accepted name and native range as recorded in WCVP, the taxonomic index of POWO (WCVP Darwin Core archive, GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2, published 2026-06-04; read 2026-10-29), 2026-06-04. powo.science.kew.org
- Fukada K, et al. Antiedema effects of Siberian ginseng in humans and its molecular mechanism of lymphatic vascular function in vitro. Nutr Res 2016;36(7):689-95 (PMID 27333960), 2016-02-28. pubmed.ncbi.nlm.nih.gov
- Bang JS, et al. Clinical effect of a polysaccharide-rich extract of Acanthopanax senticosus on alcohol hangover. Pharmazie 2015;70(4):269-73 (PMID 26012258), 2015-04. pubmed.ncbi.nlm.nih.gov
- Kuo J, et al. The effect of eight weeks of supplementation with Eleutherococcus senticosus on endurance capacity and metabolism in human. Chin J Physiol 2010;53(2):105-11 (PMID 21793317), 2010-04-30. pubmed.ncbi.nlm.nih.gov
- Hwang YC, et al. The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal women. J Bone Miner Metab 2009;27(5):584-90 (PMID 19452124), 2009-05-20. pubmed.ncbi.nlm.nih.gov
- Lee YJ, et al. The effects of A. senticosus supplementation on serum lipid profiles, biomarkers of oxidative stress, and lymphocyte DNA damage in postmenopausal women. Biochem Biophys Res Commun 2008;375(1):44-8 (PMID 18671947), 2008-07-29. pubmed.ncbi.nlm.nih.gov
- Cicero AF, et al. Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial. Arch Gerontol Geriatr Suppl 2004;(9):69-73 (PMID 15207399), 2004. pubmed.ncbi.nlm.nih.gov
- Eschbach LF, et al. The effect of siberian ginseng (Eleutherococcus senticosus) on substrate utilization and performance. Int J Sport Nutr Exerc Metab 2000;10(4):444-51 (PMID 11099371), 2000-12. pubmed.ncbi.nlm.nih.gov
- Szołomicki J, et al. The influence of active components of Eleutherococcus senticosus on cellular defense and physical fitness in man. Phytother Res 2000;14(1):30-5 (PMID 10641044), 2000-02. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.